![](/img/cover-not-exists.png)
PCN90 - COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS OF NILOTINIB FOR THE SECOND LINE TRATMENT OF CHRONIC MIELOID LEUKEMIA IN THE RUSSIAN FEDERATION
Avxentyev, N.A., Frolov, M.Y., Makarov, A.S.Volume:
21
Journal:
Value in Health
DOI:
10.1016/j.jval.2018.09.172
Date:
October, 2018
File:
PDF, 370 KB
2018